These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8921086)

  • 1. Supraphysiological serum relaxin concentration during pregnancy achieved by in-vitro fertilization is strongly correlated to the number of growing follicles in the treatment cycle.
    Kristiansson P; Svärdsudd K; von Schoultz B; Wramsby H
    Hum Reprod; 1996 Sep; 11(9):2036-40. PubMed ID: 8921086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxin in sera during the luteal phase of in-vitro fertilization cycles.
    Eddie LW; Martinez F; Healy DL; Sutton B; Bell RJ; Tregear GW
    Br J Obstet Gynaecol; 1990 Mar; 97(3):215-20. PubMed ID: 1692232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibin and relaxin concentrations in early singleton, multiple, and failing pregnancy: relationship to gonadotropin and steroid profiles.
    Norman RJ; McLoughlin JW; Borthwick GM; Yohkaichiya T; Matthews CD; MacLennan AH; de Kretser DM
    Fertil Steril; 1993 Jan; 59(1):130-7. PubMed ID: 8419200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxin secretion in in vitro fertilization pregnancies.
    Haning RV; Goldsmith LT; Seifer DB; Wheeler C; Frishman G; Sarmento J; Weiss G
    Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):233-40. PubMed ID: 8572013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum relaxin and the major endometrial secretory proteins in in-vitro fertilization and down-regulated hormone-supported and natural cycle frozen embryo transfer.
    Arthur ID; Anthony FW; Adams S; Thomas EJ
    Hum Reprod; 1996 Jan; 11(1):88-91. PubMed ID: 8671165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of human chorionic gonadotropin and pregnancy on the circulating level of relaxin.
    Johnson MR; Okokon E; Collins WP; Sharma V; Lightman SL
    J Clin Endocrinol Metab; 1991 May; 72(5):1042-7. PubMed ID: 2022705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of oestradiol-17beta, progesterone, relaxin and chorionic gonadotrophin during blastocyst implantation in natural pregnancy cycle and in embryo transfer cycle in the rhesus monkey.
    Ghosh D; Stewart DR; Nayak NR; Lasley BL; Overstreet JW; Hendrickx AG; Sengupta J
    Hum Reprod; 1997 May; 12(5):914-20. PubMed ID: 9194639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benefits of mid-luteal addition of human chorionic gonadotrophin in in-vitro fertilization using a down-regulation protocol and luteal support with progesterone.
    Herman A; Raziel A; Strassburger D; Soffer Y; Bukovsky I; Ron-El R
    Hum Reprod; 1996 Jul; 11(7):1552-7. PubMed ID: 8671503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
    Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
    Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies.
    Paoletti AM; Serra GG; Mais V; Ajossa S; Guerriero S; Orrù M; Melis GB
    J Assist Reprod Genet; 1995 Apr; 12(4):263-8. PubMed ID: 7580023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations of relaxin, chorionic gonadotropin, estradiol-17 beta, and progesterone during the reproductive cycle of the chimpanzee (Pan troglodytes).
    Steinetz BG; Randolph C; Mahoney CJ
    Endocrinology; 1992 Jun; 130(6):3601-7. PubMed ID: 1597157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization.
    Devroey P; Fauser BC; Platteau P; Beckers NG; Dhont M; Mannaerts BM
    J Clin Endocrinol Metab; 2004 May; 89(5):2062-70. PubMed ID: 15126522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone alone versus progesterone combined with HCG as luteal support in GnRHa/HMG induced IVF cycles: a randomized clinical trial.
    Mochtar MH; Hogerzeil HV; Mol BW
    Hum Reprod; 1996 Aug; 11(8):1602-5. PubMed ID: 8921100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy and birth after high serum progesterone concentrations during the follicular phase in an in-vitro fertilization cycle with gonadotrophin-releasing hormone agonist suppression.
    Ubaldi F; Smitz J; Bourgain C; Van Steirteghem A; Devroey P
    Hum Reprod; 1995 Jan; 10(1):211-3. PubMed ID: 7745057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
    Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
    Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular flushing in natural cycle IVF does not affect the luteal phase - a prospective controlled study.
    von Wolff M; Kohl Schwartz A; Stute P; Fäh M; Otti G; Schürch R; Rohner S
    Reprod Biomed Online; 2017 Jul; 35(1):37-41. PubMed ID: 28483339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone.
    Claman P; Domingo M; Leader A
    Hum Reprod; 1992 Apr; 7(4):487-9. PubMed ID: 1522190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal characteristics in the early luteal phase of conceptive and nonconceptive menstrual cycles.
    Chen J; Qiu Q; Lohstroh PN; Overstreet JW; Lasley BL
    J Soc Gynecol Investig; 2003 Jan; 10(1):27-31. PubMed ID: 12517590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.